Favourable tumour outcomes are reported in SCLC patients with LEMS [12] and HuD PEM [13,14]; their neuronal antibodies (Neur-Abs) may be a reflection of more potent anti-tumour immunity. The gene discussed is NCAN; the disease is neoplasm.